PGEN
Precigen Inc
Price:  
3.59 
USD
Volume:  
6,590,990.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PGEN EV/EBITDA

-235.4%
Upside

As of 2025-09-16, the EV/EBITDA ratio of Precigen Inc (PGEN) is -11.13. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PGEN's latest enterprise value is 1,273.30 mil USD. PGEN's TTM EBITDA according to its financial statements is -114.39 mil USD. Dividing these 2 quantities gives us the above PGEN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 12.3x - 16.2x 14.5x
Forward P/E multiples 13.0x - 19.7x 16.2x
Fair Price (4.12) - (5.14) (4.86)
Upside -214.8% - -243.1% -235.4%
3.59 USD
Stock Price
(4.86) USD
Fair Price

PGEN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-09-15 -11.13
2025-09-12 -11.76
2025-09-11 -12.85
2025-09-10 -12.67
2025-09-09 -12.82
2025-09-08 -12.92
2025-09-05 -13.54
2025-09-04 -14.17
2025-09-03 -14.77
2025-09-02 -14.80
2025-08-29 -14.01
2025-08-28 -14.14
2025-08-27 -14.26
2025-08-26 -13.23
2025-08-25 -12.35
2025-08-22 -12.98
2025-08-21 -11.29
2025-08-20 -9.94
2025-08-19 -9.97
2025-08-18 -9.13
2025-08-15 -9.09
2025-08-14 -5.68
2025-08-13 -5.87
2025-08-12 -5.52
2025-08-11 -5.33
2025-08-08 -5.46
2025-08-07 -5.77
2025-08-06 -5.61
2025-08-05 -5.93
2025-08-04 -5.40
2025-08-01 -5.11
2025-07-31 -5.24
2025-07-30 -5.30
2025-07-29 -4.80
2025-07-28 -4.83
2025-07-25 -4.80
2025-07-24 -4.89
2025-07-23 -5.08
2025-07-22 -4.64
2025-07-21 -5.61
2025-07-18 -5.40
2025-07-17 -5.58
2025-07-16 -5.65
2025-07-15 -5.68
2025-07-14 -5.99
2025-07-11 -5.61
2025-07-10 -5.87
2025-07-09 -5.83
2025-07-08 -5.21
2025-07-07 -4.86